Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urinary Tract Calculi III: Medical Management

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

Urinary Tract Calculi VI: Surgical Management

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Focal Cryo-Ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.

Urology·2026

Same author

Indigo Carmine Visualization Duration in Urine: A Randomized Kinetics Study.

Urogynecology (Philadelphia, Pa.)·2026

Same author

How urology can embrace the patient-centric precision focal therapy approach for localized prostate cancer.

Nature reviews. Urology·2026

Same author

Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity.

Advances in radiation oncology·2026

Same author

Qualitative assessment of facilitators and barriers to testicular torsion care: Findings from the testicular torsion collaborative.

Journal of pediatric urology·2026

Same author

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.

European radiology·2026

Same journal

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026

Same journal

We Care, and We Will Listen.

Primary care·2026

Same journal

Addressing Sexual Health in Primary Care.

Primary care·2026

Same journal

Diagnosis and Management of Eating Disorders in Adolescents and Young Adults.

Primary care·2026

Same journal

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment.

Primary care·2026

Same journal

Nonpharmacologic Management of Insomnia Disorder in Primary Care.

Primary care·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

Published on: March 6, 2018

Benign prostatic hyperplasia: current clinical practice.

Bob Djavan¹, Elisabeth Eckersberger, Julia Finkelstein

¹Department of Urology, New York University School of Medicine, New York University Hospital, 150 East 32nd Street, New York, NY 10016, USA. bdjavan@hotmail.com

|August 14, 2010

Summary

This summary is machine-generated.

Benign prostatic hyperplasia (BPH), a common condition in aging men, causes bladder obstruction. Effective medical treatments, including alpha-adrenergic blockers and 5-alpha-reductase inhibitors, now dominate BPH management.

More Related Videos

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).

Published on: March 6, 2018

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Area of Science:

Urology
Men's Health
Pharmacology

Background:

Benign prostatic hyperplasia (BPH) is the most prevalent benign adenoma in men, impacting nearly all.
BPH causes clinically significant bladder outflow obstruction in up to 40% of men.
Increased life expectancy and earlier medical consultation contribute to rising BPH diagnoses.

Purpose of the Study:

To review the evolving management strategies for Benign Prostatic Hyperplasia (BPH).
To highlight the shift towards medical and minimally invasive therapies in BPH treatment.
To emphasize the advancements in pharmacological interventions for BPH.

Main Methods:

Literature review of recent advancements in BPH management.
Analysis of therapeutic trends over the last decade.
Evaluation of the efficacy of alpha-adrenergic blockers and 5-alpha-reductase inhibitors.

Main Results:

Medical therapies and minimally invasive procedures are now the primary treatment choices for BPH.
Alpha-adrenergic blockers and 5-alpha-reductase inhibitors have emerged as effective treatments.
Combined use of these medications represents a significant therapeutic advance.

Conclusions:

The management of BPH has significantly evolved, with a focus on effective medical therapies.
Pharmacological interventions, particularly alpha-adrenergic blockers and 5-alpha-reductase inhibitors, offer substantial benefits.
Combined therapy shows promise as a key advancement in treating BPH and its associated obstruction.